Skip to main content

Liothyronine sodium

NDC 68382-584 · Zydus Pharmaceuticals (USA) Inc.

Generic nameLiothyronine sodium
Dosage formTABLET
RouteORAL
Active ingredient(s)LIOTHYRONINE SODIUM
Strength50 ug/1
Pharmacologic classTriiodothyronine [CS], l-Triiodothyronine [EPC]
Marketing categoryANDA

Packages

68382-584-01 — 100 TABLET in 1 BOTTLE (68382-584-01)

68382-584-10 — 1000 TABLET in 1 BOTTLE (68382-584-10)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

59762-1208 — liothyronine sodium, 60793-115 — liothyronine sodium, 60793-116 — liothyronine sodium, 60793-117 — liothyronine sodium, 62756-589 — liothyronine sodium, 62756-590 — liothyronine sodium, 62756-591 — liothyronine sodium, 68071-3571 — Liothyronine Sodium, 68382-582 — Liothyronine sodium, 68382-583 — Liothyronine sodium, 68788-7269 — Liothyronine Sodium, 70377-114 — Liothyronine sodium, 70377-115 — Liothyronine sodium, 70377-116 — Liothyronine sodium, 70771-1606 — Liothyronine sodium, 70771-1607 — Liothyronine sodium, 70771-1608 — Liothyronine sodium, 71205-150 — Liothyronine Sodium, 71335-0166 — Liothyronine Sodium, 71335-0341 — Liothyronine Sodium, +30 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels